Genetic screening for thrombophilia identified a heterozygous 5G/4G polymorphism in the plasminogen activator inhibitor-1 (PAI-1) gene, while Factor V Leiden testing was negative (wild-type GG genotype). Here, SERPINE1 is linked to thrombophilia.